[go: up one dir, main page]

EP1877058A4 - Utilisation de phytotoxines pour applications veterinaires - Google Patents

Utilisation de phytotoxines pour applications veterinaires

Info

Publication number
EP1877058A4
EP1877058A4 EP06752321A EP06752321A EP1877058A4 EP 1877058 A4 EP1877058 A4 EP 1877058A4 EP 06752321 A EP06752321 A EP 06752321A EP 06752321 A EP06752321 A EP 06752321A EP 1877058 A4 EP1877058 A4 EP 1877058A4
Authority
EP
European Patent Office
Prior art keywords
phycotoxins
veterinary applications
veterinary
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06752321A
Other languages
German (de)
English (en)
Other versions
EP1877058A2 (fr
Inventor
Nestor Antonio Lagos Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phytotox Ltd
Original Assignee
Phytotox Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phytotox Ltd filed Critical Phytotox Ltd
Publication of EP1877058A2 publication Critical patent/EP1877058A2/fr
Publication of EP1877058A4 publication Critical patent/EP1877058A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP06752321A 2005-05-05 2006-05-05 Utilisation de phytotoxines pour applications veterinaires Withdrawn EP1877058A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67793305P 2005-05-05 2005-05-05
PCT/US2006/017449 WO2006119499A2 (fr) 2005-05-05 2006-05-05 Utilisation de phytotoxines pour applications veterinaires

Publications (2)

Publication Number Publication Date
EP1877058A2 EP1877058A2 (fr) 2008-01-16
EP1877058A4 true EP1877058A4 (fr) 2008-06-25

Family

ID=37308745

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06752321A Withdrawn EP1877058A4 (fr) 2005-05-05 2006-05-05 Utilisation de phytotoxines pour applications veterinaires

Country Status (5)

Country Link
EP (1) EP1877058A4 (fr)
JP (1) JP2008540452A (fr)
AU (1) AU2006243644A1 (fr)
CA (1) CA2606315A1 (fr)
WO (1) WO2006119499A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110831945B (zh) * 2017-03-29 2023-08-08 赛特温治疗公司 用于治疗疼痛的11,13-修饰的石房蛤毒素类化合物
EP3860714B1 (fr) 2018-10-03 2023-09-06 Siteone Therapeutics, Inc. Saxitoxines 11,13-modifiées destinées au traitement de la douleur

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024419A1 (fr) * 1998-10-27 2000-05-04 Mayo Foundation For Medical Education And Research Methodes visant a faciliter la cicatrisation d'une plaie
WO2005110275A1 (fr) * 2004-05-07 2005-11-24 Phytotox Limited Methodes de traitement des plaies avec les gonyautoxines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0402268A2 (hu) * 2001-11-15 2005-02-28 Micro Algae Corp. 3,4-propinoperhidropurinokat tartalmazó gyógyászati kompozíciók és alkalmazásuk ingerületátvitel gátlására

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024419A1 (fr) * 1998-10-27 2000-05-04 Mayo Foundation For Medical Education And Research Methodes visant a faciliter la cicatrisation d'une plaie
WO2005110275A1 (fr) * 2004-05-07 2005-11-24 Phytotox Limited Methodes de traitement des plaies avec les gonyautoxines
WO2005110417A1 (fr) * 2004-05-07 2005-11-24 Phytotox Limited Les phycotoxines et leur utilisation

Also Published As

Publication number Publication date
EP1877058A2 (fr) 2008-01-16
WO2006119499A2 (fr) 2006-11-09
AU2006243644A1 (en) 2006-11-09
WO2006119499A3 (fr) 2006-12-28
JP2008540452A (ja) 2008-11-20
CA2606315A1 (fr) 2006-11-09

Similar Documents

Publication Publication Date Title
TWI561237B (en) Substituted dihydropyrazolones and their use
ZA200810323B (en) Fkbp-l and uses thereof
IL189609A0 (en) 4-substituted pyrrolidin-2-ones and their use
SI2064327T1 (sl) DBAIT in njegova uporaba
PL2001556T3 (pl) Związki tioniny i ich zastosowanie
GB0512940D0 (en) Compounds and their use
IL194899A0 (en) Amino-ethyl-amino-aryl (aeaa) compounds and their use
ZA200903906B (en) Carboranylporphyrins and uses thereof
IL189252A0 (en) Dihydroxyanthraquinones and their use
GB0611115D0 (en) Compounds and their use
ZA200707903B (en) Colourant compositions and their use
EP1888560A4 (fr) Nouveaux composes de dipodazine et leurs applications
GB0520743D0 (en) Compounds and their use
DK2392335T3 (en) Use of 24-norUDCA
GB0624565D0 (en) Veterinary composition
IL192820A0 (en) Novel compounds and use thereof
GB0508991D0 (en) Veterinary composition
EP1877058A4 (fr) Utilisation de phytotoxines pour applications veterinaires
GB0619611D0 (en) Compounds and their use
GB0600336D0 (en) Composition and uses thereof
GB0513176D0 (en) Compounds and their use
GB0521278D0 (en) Compounds and their use
GB0616577D0 (en) Compounds and their use
GB0603378D0 (en) Compounds and their use
GB0608846D0 (en) Compounds and their use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071102

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20080526

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/70 20060101ALI20080519BHEP

Ipc: A61P 21/02 20060101ALI20080519BHEP

Ipc: A61K 31/519 20060101AFI20080519BHEP

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20080919

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20091105